REQUEST A DEMO
Total
USD $0.00
Search more companies

Instytut Ozonoterapii Salus Sp. z o.o. sp. k. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Retail Trade | Offices of Physicians | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | Other Personal Care Services
Full name: Instytut Ozonoterapii Salus Sp. z o.o. sp. k. Profile Updated: August 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Instytut Ozonoterapii Salus Sp. z o.o. sp. k. is based in Poland. The head office is in Warsaw. The enterprise operates in the General Medical and Surgical Hospitals industry. The company was established on August 09, 2018. In its most recent financial highlights, the company reported a net sales revenue increase of 15.11% in 2022. A negative growth of 44.99% was recorded in its total assets. Instytut Ozonoterapii Salus Sp. z o.o. sp. k.’s net profit margin decreased by 3.75% in 2022.

Headquarters
Ul. Batuty 7
Warsaw; Mazowieckie; Postal Code: 02-743

Contact Details: Purchase the Instytut Ozonoterapii Salus Sp. z o.o. sp. k. report to view the information.

Website: http://www.instytutozonoterapii.pl

Basic Information
Outstanding Shares:
Purchase the Instytut Ozonoterapii Salus Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
August 09, 2018
Key Executives
Company Performance
Financial values in the chart are available after Instytut Ozonoterapii Salus Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.11%
Total operating revenue
18.7%
Operating profit (EBIT)
-30.44%
EBITDA
-30.53%
Net Profit (Loss) for the Period
-32.25%
Total assets
-44.99%
Total equity
-74.52%
Operating Profit Margin (ROS)
-3.61%
Net Profit Margin
-3.75%
Return on Equity (ROE)
383.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?